...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: Resverlogix Announces Proposed Offering of Units

I'll have more to say later....but this looks very similar to last year.  

New Message
Please login to post a reply